Evidence map›Paper›PMID 35264213›Full record

Trial reportGenome medicine2022

The effects of the Green-Mediterranean diet on cardiometabolic health are linked to gut microbiome modifications: a randomized controlled trial.

Ehud Rinott, Anat Yaskolka Meir, Gal Tsaban, Hila Zelicha, Alon Kaplan, Dan Knights, Kieran Tuohy, Matthias Uwe Scholz, Omry Koren, Meir J Stampfer and 3 more

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Genome medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 107 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 6 pooled it
25.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03020186 nacompletednot on this map

Effects of Green-MED Diet Via the Gut-fat-brain Axis; DIRECT-PLUS

TypeinterventionalSponsorBen-Gurion University of the NegevRan2017 to 2019Enrolled294ConditionsAbdominal Obesity Metabolic SyndromeArmsPhysical activity, Physical activity+ MED diet, Physical activity+green MED diet
NCT06416475 phase2unknown statusnot on this mapstarted 2024, after this paper: background citation

The Effect of Wolffia Globosa (Mankai) on Glycemic Control Among Patients With Type 2 Diabetes; A 3-month Randomized Controlled Pilot Trial

TypeinterventionalSponsorBen-Gurion University of the NegevRan2024 to 2024Enrolled104ConditionsDiabetes Mellitus, Type 2ArmsMankai supplementation, Water consumption
3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 6 syntheses or guidelines pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Ehud RinottFaculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.
Anat Yaskolka MeirFaculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.
Gal TsabanFaculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.
Hila ZelichaFaculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.
Alon KaplanFaculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.
Dan KnightsBioTechnology Institute, University of Minnesota, Saint Paul, MN, 55108, USA.
Kieran TuohyDepartment of Food Quality and Nutrition, Research and Innovation Centre, Fondazione Edmund Mach, Via E. Mach 1, San Michele all'Adige, 38016, Trento, Italy.
Matthias Uwe ScholzDepartment of Food Quality and Nutrition, Research and Innovation Centre, Fondazione Edmund Mach, Via E. Mach 1, San Michele all'Adige, 38016, Trento, Italy.
Omry KorenAzrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
Meir J StampferBrigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Dong D WangBrigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Iris Shai *The Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. irish@bgu.ac.il.
Ilan Youngster *Pediatric Division and Center for Microbiome Research, Shamir Medical Center, Be'er Ya'akov, Israel. youngsteri@shamir.gov.il.ORCID 0000-0001-5233-1213
Ben-Gurion University of the Negev · ILBrigham and Women's Hospital · USFondazione Edmund Mach · ITBar-Ilan University · ILTel Aviv University · ILUniversity of Minnesota · US

Funding

The Gut Microbiome and Personalized Mediterranean Diet Interventions for Cardiometabolic Disease PreventionR01NR019992 · NINR · BRIGHAM AND WOMEN'S HOSPITAL · PI WANG, DONG · 2021 to 2025
$3.8M
Mediterranean Diet, Polyphenol-Rich Foods, Gut Microbiota and Type 2 DiabetesR00DK119412 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI WANG, DONG · 2020 to 2022
$747k
Mediterranean Diet, Polyphenol-Rich Foods, Gut Microbiota and Type 2 DiabetesK99DK119412 · NIDDK · HARVARD SCHOOL OF PUBLIC HEALTH · PI WANG, DONG · 2018 to 2019
$181k
NIDDK NIH HHS K99 DK119412NIDDK NIH HHS R00 DK119412NINR NIH HHS R01 NR019992
6 · The paper itself

Abstract

backgroundPrevious studies have linked the Mediterranean diet (MED) with improved cardiometabolic health, showing preliminary evidence for a mediating role of the gut microbiome. We recently suggested the Green-Mediterranean (Green-MED) diet as an improved version of the healthy MED diet, with increased consumption of plant-based foods and reduced meat intake. Here, we investigated the effects of MED interventions on the gut microbiota and cardiometabolic markers, and the interplay between the two, during the initial weight loss phase of the DIRECT-PLUS trial.

methodsIn the DIRECT-PLUS study, 294 participants with abdominal obesity/dyslipidemia were prospectively randomized to one of three intervention groups: healthy dietary guidelines (standard science-based nutritional counseling), MED, and Green-MED. Both isocaloric MED and Green-MED groups were supplemented with 28g/day walnuts. The Green-MED group was further provided with daily polyphenol-rich green tea and Mankai aquatic plant (new plant introduced to a western population). Gut microbiota was profiled by 16S rRNA for all stool samples and shotgun sequencing for a select subset of samples.

resultsBoth MED diets induced substantial changes in the community structure of the gut microbiome, with the Green-MED diet leading to more prominent compositional changes, largely driven by the low abundant, "non-core," microorganisms. The Green-MED diet was associated with specific microbial changes, including enrichments in the genus Prevotella and enzymatic functions involved in branched-chain amino acid degradation, and reductions in the genus Bifidobacterium and enzymatic functions responsible for branched-chain amino acid biosynthesis. The MED and Green-MED diets were also associated with stepwise beneficial changes in body weight and cardiometabolic biomarkers, concomitantly with the increased plant intake and reduced meat intake. Furthermore, while the level of adherence to the Green-MED diet and its specific green dietary components was associated with the magnitude of changes in microbiome composition, changes in gut microbial features appeared to mediate the association between adherence to the Green-MED and body weight and cardiometabolic risk reduction.

conclusionsOur findings support a mediating role of the gut microbiome in the beneficial effects of the Green-MED diet enriched with Mankai and green tea on cardiometabolic risk factors.

trial registrationThe study was registered on ClinicalTrial.gov ( NCT03020186 ) on January 13, 2017.

Indexed as

Cardiovascular DiseasesDiet, MediterraneanGastrointestinal MicrobiomeAmino Acids, Branched-ChainBiomarkersDietHumansRNA, Ribosomal, 16STeaWeight LossAmino Acids, Branched-ChainBiomarkersRNA, Ribosomal, 16STeaCardiometabolic healthMeatMediterranean dietMicrobiotaNutritionPolyphenolsWeight loss

Identifiers

PMID35264213
PMCPMC8908597
OpenAlexW4221108866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.